Inhibition of infection of mammalian cells by respiratory syncytial virus

摘要

The infection of mammalian cells by RSV may be inhibited by native human beta -casein, a recombinant form of human beta -casein, and hydrolysates of both. The human beta -casein or hydrolysate may be contained in a liquid enteral nutritional product such as an infant formula. The enteral nutritional product may be used, for example, in the prevention and treatment of respiratory tract infection in infants. The human beta -casein or hydrolysate may also be administered as a throat spray or nasally using drops or a spray.